P. Adami et al., MONOCLONAL-ANTIBODIES FOR STRUCTURE-FUNCTION STUDIES OF (R)-3-HYDROXY-BUTYRATE DEHYDROGENASE, A LIPID-DEPENDENT MEMBRANE-BOUND ENZYME, Biochemical journal, 292, 1993, pp. 863-872
Monoclonal antibodies (mAbs) have been used to study structure-functio
n relationships of (R)-3-hydroxybutyrate dehydrogenase (BDH) (EC 1.1.1
.30), a lipid-requiring mitochondrial membrane enzyme with an absolute
and specific requirement for phosphatidylcholine (PC) for enzymic act
ivity. The purified enzyme (apoBDH, devoid of phospholipid and thereby
inactive) can be re-activated with preformed phospholipid vesicles co
ntaining PC or by short-chain soluble PC. Five of six mAbs cross-react
with BDH from bovine heart and rat liver, including two mabs to confo
rmational epitopes. One mAb was found to be specific for the C-termina
l sequence of BDH and served to: (1) map endopeptidase cleavage and ep
itope sites on BDH; and (2) demonstrate that the C-terminus is essenti
al for the activity of BDH. Carboxypeptidase cleavage of only a few (l
ess-than-or-equal-to 14) C-terminal amino acids from apoBDH (as detect
ed by the loss of C-terminal epitope for mAb 3-10A) prevents activatio
n by either bilayer or soluble PC. Further, for BDH in bilayers contai
ning PC, the C-terminus is protected from carboxy-peptidase cleavage,
whereas in bilayers devoid of PC the C-terminus is cleaved, and subseq
uent activation by PC is precluded. We conclude that: (1) the C-termin
us of BDH is essential for enzymic activity, consistent with the predi
ction, from primary sequence analysis, that the PC-binding site is in
the C-terminal domain of BDH; and (2) the allosteric activation of BDH
by PC in bilayers protects the C-terminus from carboxypeptidase cleav
age, indicative of a PC-induced conformational change in the enzyme.